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Abstract
Fibrous tissue growth and loss of residual hearing after cochlear implantation can be reduced by application of the
glucocorticoid dexamethasone-21-phosphate-disodium-salt (DEX). To date, sustained delivery of this agent to the cochlea
using a number of pharmaceutical technologies has not been entirely successful. In this study we examine a novel way of
continuous local drug application into the inner ear using a refillable hydrogel functionalized silicone reservoir. A PEG-based
hydrogel made of reactive NCO-sP(EO-stat-PO) prepolymers was evaluated as a drug conveying and delivery system in vitro
and in vivo. Encapsulating the free form hydrogel into a silicone tube with a small opening for the drug diffusion resulted in
delayed drug release but unaffected diffusion of DEX through the gel compared to the free form hydrogel. Additionally,
controlled DEX release over several weeks could be demonstrated using the hydrogel filled reservoir. Using a guinea-pig
cochlear trauma model the reservoir delivery of DEX significantly protected residual hearing and reduced fibrosis. As well as
being used as a device in its own right or in combination with cochlear implants, the hydrogel-filled reservoir represents a
new drug delivery system that feasibly could be replenished with therapeutic agents to provide sustained treatment of the
inner ear.
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Introduction
Hearing loss affects approximately 278 million people world-
wide. Next to infectious causes like meningitis, measles, mumps
and chronic ear infections, hearing impairment is commonly
triggered by exposure to excessive noise, head and ear injury,
ageing and the use of ototoxic drugs [1]. Since sensory cells of the
inner ear develop exclusively during embryogenesis and are not
programmed to regenerate postnatally in mammals [2], in many
cases hearing ability can only be regained by the insertion of a
cochlear implant (CI) [3].
After CI surgery the acuity of residual hearing and that of CI-
mediated hearing are often affected by postoperative intra-
cochlear fibroblast growth and a delayed degeneration of neuronal
tissue. A histological evaluation of human temporal bones from
cochlear implant patients showed fibrous growth formation in
57% of examined cases. The fibrous growth formation were
believed to be as a result of intra-cochlear mechanical trauma to
the fine structures caused by electrode insertion as well as a foreign
body reaction of the host tissue to the implant [4]. As a
consequence, increased impedance, reduced speech perception
and functional derogation of the device itself may take place [5].
Locally applied glucocorticoid receptor agonists like dexameth-
asone suppress inflammation in the inner ear and consequently
prohibit growth of fibrosis related connective tissue expanse, cell
degeneration and loss of residual hearing [6,7]. Due to the relative
difficulty in accessing the inner ear, the maintenance of sufficient
therapeutic levels of this agent over a prolonged period has been
problematic. Available application aids like pump systems and
intra-cochlear electrode array loaded with dexamethasone have
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limited delivery duration, are not rechargeable and/or have to be
detached after entirely emitting the drug (reviewed by [8]).
Polyethylene glycol (PEG) based hydrogels are one of the widely
studied biomaterial as tissue culture scaffold and as drug loading
and delivery system [9–11]. Briefly, hydrogels are three dimen-
sionally cross-linked hydrophilic polymer chains that exhibit strong
swelling in water and available as degradable or non-degradable
depending on the polymer chain chemistry [12]. Non-degradable
hydrogel in the free form state loaded with any water soluble low
molecular weight drug molecules will be diffused out completely
within 24–48 hours depending on how big is the volume of release
medium. For the delayed release of drug for at least 4 week time
for inner ear treatment, the drug loaded hydrogel has to be
physically restricted from release medium which can be achieved
by incorporating the drug loaded hydrogel within the thin
electrode array. The electrical impedance of the CI which is a
hint of fibrous tissue growth is largely taking place in the first 4
weeks of implantation [13].
We have previously shown that six-arm star shaped poly-
(ethylene oxide-stat-propylene oxide) prepolymers with 80%
ethylene oxide (EO) content in the backbone and reactive
isocyanate groups at the distal ends of the arms (NCO-sP(EO-
stat-PO) can be used to prepare ultra-thin biocompatible coatings
that very efficiently minimize unspecific protein adsorption [14].
We have also shown that NCO-sP(EO-stat-PO) may be used to
prepare physiologically stable three-dimensional hydrogels [15]
and as cross-linker to polysaccharides [16].
In this study, we evaluated the physiologically stable NCO-
sP(EO-stat-PO) hydrogel as drug carrier of dexamethasone 21-
phosphate disodium salt (referred to as DEX in the manuscript), a
hydrophilic modification of dexamethasone with high water
solubility, in silicone tubes that connect the inner ear with an
external potentially refillable drug reservoir. In order to evaluate
the potential use of this hydrogel system together with an implant,
we have assessed the processes regarding its filling into silicone
tubes, drying for shelf-storage, heat-treatment for sterilization and
re-swelling after time to examine tight fit at the inner lumen of the
silicone tube. Drug release from the hydrogels was first examined
as free gels without outer steric restriction in order to show pure
diffusion controlled release. Subsequently, drug release kinetics
were examined with the hydrogel filled into a silicone tube with
one end open and PBS (pH 7.4) as the release medium.
Additionally, the hydrogel was studied as drug diffusion gateway
for a drug reservoir made of silicone tubing. In order to
understand the drug diffusion behaviour, the hydrogel was primed
and replenished with DEX. For in vivo evaluation, hydrogel
reservoirs were used to deliver DEX into the inner ear in a guinea
pig model. Reservoirs primed with PBS only as well as reservoirs
being implanted and immediately explanted served as control. The
response of the cochlea in terms of foreign body reaction and
hearing loss were examined four weeks following the implantation
procedure.
Materials and Methods
1. In vitro experiments
Star-shaped poly-ethers with a backbone of statistically copo-
lymerized 80% ethylene oxide and 20% propylene oxide,
molecular weight of 18000 g/mol (PD=1.15) with isocyanate
(NCO) end groups (NCO-sP(EO-stat-PO) was synthesized as
described previously [17]. An overview on the chemical structure
of the gel precursor and the cross-linking reaction is shown in Fig.
S2. Dexamethasone 21-phosphate disodium salt (DEX; molecular
weight 516.4 g/mol) was purchased from Sigma-Aldrich Ger-
many. Silicone tubes of 6 cm length with an internal diameter of
0.31 mm and an outer diameter of 0.64 mm were kindly provided
by MED-EL GmbH, Austria.
1.1. Hydrogel preparation and determination of the
swelling ratio. Hydrogels were prepared by dissolution of the
reactive NCO-sP(EO-stat-PO) precursors in water as described
before [15]. The cross-linked hydrogels were dried to xerogel
condition in triplets in a vacuum chamber overnight and the dry
weights were measured. Xerogels were then placed in an excess of
phosphate buffered saline (PBS; pH 7.4) at 37uC for studying its
swelling kinetics. The weight of the swollen gel was measured at
specific time intervals until it reached its equilibrium swelling state.
The swelling ratio is determined by the ratio of dry weight of the
gel (Wd) to the swollen weight of the gel (Ws): swelling ratio =
(Wd/Ws)6100.
1.2. Drug release studies from free 3D hydrogels. NCO-
sP(EO-stat-PO) was dissolved in a 50 mg/mL (w/v) DEX solution
in PBS (pH 7.4) to a final concentration of 20% (w/v).
Subsequently, 0.5 mL of this solution (containing 25 mg DEX)
was placed into a Teflon mould of 15 mm diameter and 3 mm
depth and covered airtight for 24 hours. After completed cross-
linking, the DEX-loaded hydrogel was dried to zerogel in a
vacuum chamber and then placed in PBS at 37uC for swelling and
release of the drug molecules. The amount of drug released in to
the PBS was measured by CARY 100 Bio UV-visible spectro-
photometer at selected time intervals until the minimum detection
limits were reached. The wavelength used to detect DEX was
238–242 nm.
1.3. Drug release from hydrogels in silicone tubes. PBS
solution containing DEX (50 mg/mL) was used to dissolve
homogenously the hydrogel precursor to obtain a 20% w/v
concentration. By use of an insulin syringe avoiding air bubbles,
the gellifying solution was sucked inside the silicon tubes of length
60 mm and an inner diameter of 0.31 mm with one end open and
the other end closed. The silicone tubes were sealed for 24 hours
to allow complete gelation and to prevent drying. Subsequently
the silicone tubes containing the hydrogel were placed in PBS at
37uC to examine the release of DEX as mentioned in section
1.1.2.
1.4. Hydrogel as diffusion gate in drug reservoir. NCO-
sP(EO-stat-PO) was dissolved in PBS and sucked inside a silicone
tube from the open end for a length of 10, 5 and 2 mm and
maintained undisturbed for 24 hours. After cross-linking of the
hydrogel, the remaining length of the silicone tube between the
closed end and the hydrogel was filled with DEX solution
(100 mg/mL) using an insulin syringe. This set-up was again
placed in PBS at 37uC to investigate the release profile of DEX as
mentioned in section 1.1.2.
2. In vivo experiments
Normal hearing Dunkin Hartley guinea pigs (n = 28; Harlan-
Winkelmann GmbH, Borchen, Germany) of both sexes, weighing
about 400 g were used. All experiments were carried out in
accordance with the institutional guidelines for animal welfare of
Hannover Medical School following the standards described by
both German laws on protecting animals (Tierschutzgesetz) and
the European Communities Council Directive 86/609/EEC for
the protection of animals used for experimental purposes. The
experiments of this study were approved by the regional
government (Niedersa¨chsisches Landesamtes fu¨r Verbrau-
cherschutz und Lebensmittelsicherheit, LAVES, registration
no. 10/0137).
2.1. Hydrogel reservoir. Using a syringe, the NCO-sP(EO-
stat-PO) solution was filled into the hollow silicone reservoirs
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(4.32 mL total volume). One end of the reservoir was equipped
with a silicone septum which could be perforated with a tuberculin
syringe with a needle diameter of 0.5 mm for sterile injection of
DEX solution. To allow for a less traumatic implantation, each
reservoir tip was smoothed down but remained unsealed in order
to release DEX from the hydrogel. After being filled the reservoir
was sterilized using ethylene oxide. DEX priming was performed
during surgery immediately before reservoir insertion into the
inner ear.
DEX sodium phosphate (Spectrum chemical MFG. Corp.,
Gardena, California, USA) was dissolved in PBS (PBS tablets,
Invitrogen Corporation, Paisley, Scotland, UK). The DEX
concentration in PBS was 50 mg/ mL for both HPLC and in vivo
studies which necessitated a loading of 216 mg DEX per reservoir.
2.2. Acoustically evoked auditory brainstem response
measurement. Before surgery (day 0) and subsequently on day
3, 7, 14, 21 and 28, animals were anesthetized (diazepam 2.5 mg/
kg p.o., atropine sulfate 0.05 mg/kg s.c., ketamine 30 mg/kg i.m.,
xylazine 7.5 mg/kg i.m.) in order to perform frequency-specific
acoustically evoked auditory brainstem response measurements
(AABR). All animals were treated with subcutaneous (s.c.)
injections of carprofen (0.5 mg/kg), and atropine (0.05 mg/kg)
for analgesia and reduction of secretion respectively.
Four needle electrodes were inserted s.c.: a positive pole at the
vertex, a ground electrode in the neck, and negative poles
postauricularily on the mastoids. The guinea pigs were placed in a
soundproof box positioned on a heating pad with a temperature of
37uC. Speakers were connected to the acoustic meatus by
calibrated pipette tips.
For frequency-specific acoustic stimulation and measurement,
hardware and software from Tucker-Davis Technologies (Ala-
chua, FL, USA) were used. Stimuli were 10 ms pure tones with a
cosine-squared rise-fall time of 1 ms (24-bit Sigma-Delta D/A
conversion at 200 kHz sampling rate). Six different frequencies (1,
4, 8, 16, 32, and 40 kHz) generated in 10 dB steps from 20 to 90
dB SPL (decibel sound pressure level) were presented using the
TDT software (BioSigRP). The recorded neural signals were
digitized at 24 kHz sampling rate (16-bit) and bandpass filtered
between 0.3 to 3 kHz. The measurements of every frequency and
sound intensity were recorded 270 times and averaged.
For evaluation purposes, data were exported into Microsoft
Excel (Microsoft Corporation, Redmond, Washington, Seattle,
USA) where the recordings were graphed and the triple standard
deviation (SD) of background noise of each measurement,
recorded in a phase of non-stimulation was calculated and plotted
graphically. Hearing threshold was defined as the lowest stimulus
level that generated a visually detected peak 3 exceeding three
times SD. In the case where no hearing threshold could be
detected at the systems limit of 90 dB SPL, the hearing threshold
was set to 100 dB SPL. For every individual, frequency specific
hearing thresholds of every measurement were compared to the
related hearing threshold determined before surgery on day 0. The
difference between the pre-surgical hearing threshold and those
following was defined as hearing loss.
2.3. Surgical procedures. Before surgery DEX solution and
PBS were prepared freshly and filled into the reservoirs (for details
see section 2.1.1).
Anaesthesia was performed similarly to that used for AABR but
the dosage of ketamine and xylazine was higher (40 mg/kg i.m.,
respectively 10 mg/kg i.m.) and animals were supplied with
enrofloxacine (10 mg/kg s.c.) for prevention of infection. Follow-
ing initial AABR measurement on day 0 the postauricular area
was bilaterally sheared placed under analgesia (1 ml prilocaine)
and disinfected. Under sterile conditions a postauricular approach
was performed to visualize the Bulla tympanica. The periosteum
was abscised and the middle ear was opened with scalpel and
forceps. Using an OP-MI microscope (Carl Zeiss AG, Oberko-
chen, Germany) the cochlea was identified and ventral to the
round window a cochleostomy was drilled in the basal turn of the
cochlea (drilling head 600 mm diameter). The reservoir was
inserted 3 mm deep into the perilympathic space of the Scala
tympani and left in situ. In an additional set of animals, reservoirs
were inserted and withdrawn immediately to serve as a control
trauma group. In all other groups the implant was fixed and the
cochleostomy and fenestration of the middle ear were sealed with
carboxylate cement (Durelon Carboxylate Cement, 3 M ESPE
AG, 82229 Seefeld, Germany). Thereafter, the protruding part of
the reservoir was rolled-up and secured s.c. and the wound was
sutured in two layers.
Animals were treated bilaterally but some ears had to be
excluded from the study due to e.g. reservoir displacement after
tissue harvesting. To summarize the treatments, 11 animals (14
ears used) were treated with DEX administered by the hydrogel
reservoir, 10 animals (12 ears used) received PBS released from the
hydrogel reservoir and 7 animals (12 ears used) served as trauma
group.
2.4. Exploitation of specimens. On day 28 guinea pigs
were anesthetised (ketamine 40 mg/kg i.m., xylazine 10 mg/kg
i.m., atropine 0.05 mg/kg s.c.), the final AABR measurement was
performed after which the sternal area of the animal was placed
under analgesia with 4 ml prilocaine (2%). The chest was opened
and the animal was perfused intracardially with 200 ml PBS and
then fixed with 200 ml of modified Wittmaack fixing solution. The
inner ears were extracted while the end section of the reservoirs
remained inside the Scala tympani.
The fenestra ovalis and the apex were pierced with a lancet and
the specimens were fixed in advanced Wittmaack fixing solution
for up to 24 hours, rinsed for 10 hours with a 4% solution of
lithium sulphate (Merck KGaA, Darmstadt, Germany) and
dehydrated (2 hours per concentration) in ascending ethanol
concentrations (50% v/v, 70% v/v 90% v/v and 100%) or
optionally overnight in 70% v/v ethanol. Afterwards they were
dried at room temperature and embedded in 5 parts epoxy resin
and 2 parts hardening agent (SpeciFix-40 Kit, Struers GmbH,
Ballerup, Denmark). Resin was adjusted by the addition of
titanium oxide for whitening and reduction of transparency.
Specimens and resin were filled into self-made silicone moulds
with an inner diameter of 3 cm and a height of 4 cm (silicone
source: SORTA Clear 40, Kaupo, Spaichingen, Germany) and
placed into vacuum until all spaces in the specimens were filled
with epoxy resin. The vaccum was slowly released and the samples
were left to harden overnight at room temperature.
2.5. Grinding, Histology. All specimens were grinded with a
grinding machine (PowerPro 4000, Bu¨hler, Lake Bluff, Illinois,
USA) and abrasive paper. After reaching the cochlea with coarse
sand paper (grain size 800) the process was then continued with
fine sandpaper (grain size 1200). For every layer of the cochlea,
20 mm were abraded and the section was stained for two minutes
with each eosine and toluidine (Merck KGaA, Darmstadt,
Germany). The freshly stained surface of the specimen was
photographically documented at 30-, 150- and 200-times magni-
fication using a Keyence system (VHX-600 DSO, Osaka, Japan).
For assessment of tissue response inside the Scala tympani,
Keyence software was used to measure the area occupied with
connective tissue in the first and the last mid-modiolar plane
section as well as that arithmetically lying in between those two
sections. The 7 cross sections of the Scala tympani per section were
titled as lower basal turn, upper basal turn, first middle turn,
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second middle turn, third middle turn, forth middle turn and
apical turn [18]. Connective tissue span was set into a ratio to the
area of the Scala tympani which were measured by tracking the
inner outline of the Scala tympani using the Keyence software.
Additionally, for every single layer and every part of the Scala
tympani (lower basal to apical turn) a subjective evaluation using a
ranking system was performed in order to monitor the distribution
of connective tissue in relation to the point of cochleostomy and
the turns of the cochlea. The rationale for subjective ranking was:
score 0: no connective tissue; score 1: less than one quarter of the
scala tympani is filled with connective tissue; score 2: less than half
but more than one quarter of the scala has to be filled with tissue
and/or the whole surface of the implants crosscut has to be
covered; and score 3: more than half of the scala tympani is filled
with connective tissue; see Fig. S1)
In order to correlate results from fibrosis evaluation and AABR
measurements, averages of the single values of every group were
composed and compared to the averaged results of hearing loss on
day 28.
2.6. Statistical Analysis. Statistical analysis was performed
using GraphPad Prism 5 (GraphPad Software Inc., La Jolla,
California, USA). Since animals were treated bilaterally, the
correlation of left and right ears of same individuals were excluded,
before using One-way ANOVA in combination with the Tukey
post-test to compare mean hearing loss and measurement or
ranking of tissue response within the turns for each group or for
grouped comparison of tissue formation in the turns. Unpaired
students t-test was used to calculate differences between results of
mean tissue growth ranking and measurement between groups.
Correlation assessment between tissue growth determined by
ranking and hearing threshold shift was performed using a
nonparametric correlation test (Spearman). Significance was
defined as p-values with * = p,0.05, ** = p,0.01, *** = p,0.001.
Results
3.1. In vitro results - Drug release studies from DEX
loaded free form hydrogels
As reported previously [19], the free-form hydrogel reached the
EWC state from dry state within 360 minutes and cryo-SEM
pictures shows the macro-porous morphology of the hydrogel in
the EWC state. (Fig. S2 and S2C). However, the pores are not
inter-connected and the molecular mesh size of the hydrogel
network remains decisive for diffusion of drug molecules through
the hydrogel. The drug release from free standing 3D hydrogels is
fully diffusion controlled and almost quantitative within 24 hours
(Fig. S3).
3.2. In vitro results - Drug release studies from hydrogels
in silicone tubes
In this configuration, the release of drug may logically occur
only through the open end of the silicone tube. The walls of the
silicone tube will restrict the hydrogel to swell to its full equilibrium
state, hence at every point of time the hydrogel will exert a swelling
force against the inner wall of the silicone tube by which the
hydrogel adjusts tightly to the inside wall of the silicone tube. The
exact dimension of the silicone tube reservoir with the amount of
drug molecule inside the hydrogel and the cumulative release
profile is shown in Fig. 1. Reproducibility of the hydrogel packing
inside the silicone tube reservoir and the kinetics of the drug
release were performed with three batches of separately prepared
DEX loaded hydrogels with each of the batches inserted in three
different tubes. Although the release of the drug happens by
diffusion process, the geometrical constraint result in a time of
about 900 hours or 38 days until DEX is quantitatively released.
Interestingly, there was only negligible release in the first 50 hours.
This may be explained by the initial diffusion of water inside the
gel such that maximal water content in the tube is reached
allowing the diffusion controlled release to start.
Figure 1. Image of a hydrogel reservoir with one end closed by a silicone septum for fluid injections (right end), while the other end
is open in order to release the drug into the area to be addressed (left end) and calculation of the amount of drug inside the
hydrogel filled tube. Drug release from this arrangement is shown in the diagram. The data points result from nine experiments from three
different NCO-sP(EO-stat-PO) batches, each of them used for the preparation of three release setups.
doi:10.1371/journal.pone.0104564.g001
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3.3. In vitro results - Drug release studies from hydrogel
as diffusion gate for drug reservoir
In this configuration, the open end of the silicone tube is filled
hydrogel for a certain length, so as to create a diffusion gate that
could possibly separate the inner ear from an externally accessible
drug reservoir. We also evaluated the possibility to dry and re-swell
the set-up and whether this would lead to a tight fit of the re-
swollen gel inside the tubes. Fig. 2 presents a series of images
showing cross-sections of silicone tubes before and after filling with
gel. In order to evaluate whether the gels remain in the tubes after
drying and re-swelling, the gels in the tubes were warmed to 50uC
under reduced pressure (100 mbar) for 30 minutes which resulted
in a strong shrinkage of the hydrogel. However, the gels remained
at the place in the tubes where they had been placed and after re-
swelling the gels tightly closed the inner lumen of the tubes without
any visible gaps, this being independent of the hydrogel gate
length.
We also checked whether longer incubation times affected the
hydrogels within the tubes with regard to signs of degradation or
morphological changes. Our results show that at least for 50 days,
no changes of the hydrogel within the tubes could be observed.
We then prepared the aforementioned hydrogel gate arrange-
ment in triplets and loaded the free space in the tubes with DEX
solutions (100 mg/mL) to study the drug release kinetics. During
this procedure (see Fig. S4 for details) it was necessary to create a
pinhole at one place in the side wall of the silicone tube. In order
to assess whether this pinhole did not result in uncontrolled release
during the studies, we checked its tightness by using a dye solution
(Fig. S5). This control experiment showed that the pinhole closes
tightly after removal of the needle and no uncontrolled release
occurs. Fig. S6 shows images of three samples with hydrogel gates
of 10, 5 and 2 mm length as well as the calculation of drug loading
and the drug release profiles. Again an initial lag-time was
observed, however with about 100 hours being twice as long. This
results from the need for DEX to diffuse through the hydrogel
gates before release can occur. Quantitative release of DEX was
reached in all three gate-length cases after approximately
1200 hours ( = 50 days).
Since DEX release started earlier in the completely gel filled
tubes and the diffusion time of DEX out of those fully filled tubes
remained for 38 days, which covers the critical time period in
cochlear implant patients, these results encouraged us to examine
whether this system would demonstrate beneficial effects in vivo.
3.4. In vivo results - AABR measurements
On experimental day 0, prior to surgery, all animals were
possessing normal hearing. No significant differences in mean
AABR thresholds, given as lowest sound intensity where the
brainstem response exceeded the triple standard deviation of the
background noise, were observed between experimental groups
across all frequencies (data not shown). Postoperatively, all groups
suffered from an initial loss of hearing detected in the average of all
frequencies measured three days after surgery: the mean 6 SEM
difference compared to the day 0 threshold was: 8.3364.52 dB
SPL in the reservoir + DEX group, 16.9467.04 dB SPL in the
reservoir + PBS group and 39.0367.28 dB SPL in the trauma
group (Fig. 3).
This hearing loss stayed statistically stable within every group
over the whole experimental time but it significantly differed
among the four groups over this time period. Significantly better
results in comparison to all other groups from day 3 until day 28
were detected in animals implanted with the reservoir applying
DEX (hearing loss on experimental day 28: 14.4261.54
(mean 6 SEM) dB SPL; preservoir + DEX vs. trauma,0.001,
preservoir + DEX vs. reservoir + PBS,0.01), whereas the highest
hearing loss (43.1761.08 (mean 6 SEM) dB SPL) was
measured in the trauma group (ptrauma vs. reservoir + DEX,0.001,
ptrauma vs. reservoir + PBS,0.001) (Fig. 3)
Concerning the frequency specific hearing loss within each
experimental group, differences are only seen between the 1 kHz
and 8 kHz spectrum of the trauma group (hearing loss at 1 kHz:
2864.55; at 8 kHz: 56.566.36 dB SPL (mean 6 SD); p,0.05;
Figure 2. Cross-section images of silicone tubes before and after filling between 2 and 10 mmwith with 20% (w/v) NCO-sP(EO-stat-
PO) gels (top left and middle), after drying of the gel (top right), re-swelling (bottom right) and after maintaining the gels in a
swollen condition for 50 days (bottom left).
doi:10.1371/journal.pone.0104564.g002
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Figure S7), or in the averaged results of all animals of all groups,
where the mean hearing loss at 1 kHz was 15.9463.35 SD dB
SPL and thus statistically lower than hearing loss at 8 kHz
(36.9564.02 SD dB SPL, p,0.01), 16 kHz (31.4764.22 SD, p,
0.05) and 32 kHz (31.4563.81 SD, p,0.05) (data not shown).
3.5. In vivo results - Tissue response
3.5.1. Ranking of tissue growth – whole cochlea
length. Using student’s t-test the evaluation of fibrotic tissue
response in the whole cochlea by use of a subjective scoring system
revealed significant differences between the three experimental
groups (Fig. 4A). The trauma group suffered from a more intense
tissue response (score: 0.8360.12 SEM) which can be statistically
underscored with a p-value of 0.0133 when compared to the
reservoir + PBS group, and p,0.001, when matched with
reservoir + DEX. The group treated with the reservoir and PBS
(0.4760.08) also achieved a higher ranking score than the
reservoir + DEX treated ones (0.2560.05 SEM; p,0.05).
3.5.2. Ranking of tissue growth - Distribution across
scalae. In all experimental groups tissue growth was signifi-
cantly worse in the basal half turns of the cochleae (Fig. 5 and S8)
compared to the apical region or the middle turns (p,0.001) (Fig.
S8). Concerning this characteristic, all groups achieved similar
tendencies. In the trauma group basal turns (lower and upper basal
turn) achieved a ranking score of 2.0460.25. Middle turns a score
Figure 3. Mean and SEM of hearing loss (difference between the experimental days hearing threshold and hearing threshold
before implantation) development from day 3 to day 28 for all experimental groups. Cochleae of the trauma group (n = 12) suffered from
highest hearing loss compared to all other experimental groups. Additionally, individuals implanted with a PBS releasing reservoir (n = 12) lost
hearing more significantly compared to the group having been implanted with the DEX filled reservoir (n = 14). The statistical differences using
ANOVA test examined on experimental day 28 are plotted at the right side of the graph, demonstrating, that the reservoir + DEX treatment resulted
in the significantly best hearing thresholds. (** = p,0.01; *** = p,0.001).
doi:10.1371/journal.pone.0104564.g003
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of 0.4260.19 and apical turns a value of 0.0860.08 (p,0.001; Fig
S8A). Basal turns of the reservoir + PBS group showed tissue
growth with a ranking score of 1.4560.16 (Fig. S8B). Middle turns
of 0.0960.05 and basal turns of the reservoir + DEX group had a
score of 0.8860.11, while middle turns received a score of
0.000460.0004 (Fig. S8C). Both of the reservoir groups exhibited
no fibrotic tissue response in the apical turns Comparison of
fibrotic tissue reaction in middle and apical turns did not show any
significant differences (Fig. S8A–C).
Differences between the experimental groups were also
demonstrated most clearly in their disparity of tissue growth in
the basal regions and the 1st middle turn. Fig. 5, illustrating tissue
growth ranking in all turns of all experimental groups, reveals the
trauma group to undergo significantly more tissue growth in the
basal turn (2.4160.23 SEM) than both reservoir groups
(ptrauma vs. reservoir+PBS,0.001, ptrauma vs. reservoir+DEX,0.001).
The amount of newly formed tissue in the upper basal turns of
all groups did not differ but the tissue in the first middle turn of the
trauma group was significantly increased compared to the
reservoir + DEX treated ones (p,0.05). In all scales more apical
to this, no statistical relevant difference could be demonstrated
among the groups and no significant differences were observed
between PBS and DEX supported cochleae at all.
3.5.3. Quantitative measurement of tissue growth-whole
cochlea length. When measuring the area of fibrotic tissue
growth and relating it to the matching area of the Scala tympani
Figure 4. Graphed t-test results of tissue growth ranking (A) and measurement (B) for the whole cochlea length. Using both evaluation
methods the tissue growth in the trauma group was significantly increased compared to the reservoir and DEX group with a p value ,0.001. When
applying the ranking score the difference between reservoir + PBS and trauma or reservoir + DEX was significant with p,0.05 (A). Comparing the
tissue growth of the reservoir + PBS group with those of the trauma group or the DEX group using the measuring method, the p value is,0.001 (PBS
vs. trauma) and ,0.05 (PBS vs. DEX). Error bars: SEM. * = p,0.05, *** = p,0.001.
doi:10.1371/journal.pone.0104564.g004
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we detected the highest tissue formation in the trauma group
where 26.7864.17% (mean 6 SEM) of the Scala tympani area
was covered with fibrotic tissue or bony structures (Fig. 4B). In
comparison to cochleae provided with the reservoir + PBS
(4.7461.11%) and reservoir + DEX (2.1460.55%) the trauma
control group suffered from significantly higher tissue proliferation
(p,0.001). A relevant difference in tissue formation was detected
in reservoir + PBS treated animals compared to DEX treated ones
as well (p,0.05).
3.5.4. Quantitative measurement of tissue growth –
Distribution across scalae. The significantly most affected
location of the cochlea are the basal turns when compared to more
apical regions (p between ,0.05 and ,0.001; Fig. S9A–C). Fig. 6
and Fig. S9 illustrate the decrease of tissue growth from the basal
to the apical parts of the cochleae. Comparisons of tissue growth
within the turns of each experimental group are plotted in Fig. S9
A–C.
Additionally, the groups showed different amounts of tissue in
the individual parts of the cochlea. In the lower basal turn trauma
group reached a tissue fraction of mean 6 SEM of 65.4169.32%
with a p-value of ,0.001 compared to the tissue response found in
the lower basal turns of reservoir + PBS group (16.1764.01%),
and reservoir + DEX group (8.2562.46%) (Fig. 6). Similar
findings are seen in the upper basal turn where the trauma group
suffered from a tissue growth of 52.36610.64%, and thus a
statistically higher tissue reaction than the reservoir + PBS group
(11.8663.88, p,0.001) and reservoir + DEX group (6.6761.95%,
p,0.001). In the 1st middle turn the differences are found in p-
values ,0.01 between trauma group with a score of
39.95612.92%, and reservoir + PBS group with a score of
3.762.91% and ,0.001 for the reservoir + DEX group with
0.0560.05%. Evaluation of the 2nd middle turn reveals a p-value
of ,0.05 for the difference between the trauma group
(27.87612.27%) and reservoir + PBS group (1.4361.43%) and
the reservoir + DEX (0%). In the 3rd middle turn of the trauma
group 1.8361.59% of the scala tympani area was filled with tissue,
which was compared to the 3rd middle turns of the PBS or DEX
treated groups, where no tissue growth was observed at all,
although this tissue reaction was not statistically relevant. In all
turns more apical to this point, no statistical distinction was found
since no tissue growth was detected apical to the 3rd turn in any of
the experimental groups (Fig. 6). Comparing the tissue growth
measured in PBS treated animals to those in DEX treated ones no
statistically relevant difference was observed even though the
tendency of higher fibrosis rate in PBS treated animals (lower
basal: 16.1764.01%; upper basal 6.6761.95%; 1st middle
3.7062.91%; 2nd middle: 1.4361.43%) compared to DEX treated
guinea pigs (lower basal: 8.2562.46%; upper basal 11.8663.88%;
1st middle 0.0560.05%; 2nd middle: 0%) (Fig. 6) was clearly seen.
3.5.5. Differences in ranking and quantitative
measurement. Results from subjective ranking of tissue reac-
tion in all images taken from the scala tympani of all experimental
animals and the findings from the tissue growth measurement
performed in three pictures of each cochlea are very similar but
significances differed between both methods when comparing the
mean values of the experimental groups. More precisely, ranking
showed a p-value of ,0.05 for the difference between the trauma
and the reservoir + PBS group (Fig. 4A), which is p,0.001
according to the measurement technique (Fig. 4B). Next to this,
the statistical results were equal.
3.5.6. Correlation of tissue growth and hearing
impairment. Tissue growth concurred with the results of
AABR measurements. A profound correlation between mean
values of the amount of tissue, determined by subjective ranking,
and the averaged hearing loss of all frequencies of the individual
animal was ascertained. It was demonstrated that with increasing
tissue growth hearing loss increased (Fig. 7A). Using the Spear-
man-Rho-tests a correlation with r = 0.6338 (p,0.001) was
detected.
Correlation between the location of new tissue formation in the
scala tympani and hearing loss at specific frequencies was detected
as well, that is to say, accumulation of tissue growth in basal parts
of the cochlea were associated with loss of hearing in high
frequencies, equally, tissue formation in the more apical cochlear
turns did accompany loss of hearing in. lower frequencies. For
example, the fibrous tissue expanse in the upper basal turn of all
evaluated cochleae corresponded significantly (p = 0.0225) to the
hearing loss detected at 32 kHz (r = 0.3742). And the other way
around, the amount of tissue detected in the 3rd middle turn
correlated significantly to the hearing loss at 1 kHz (p= 0.00231;
r = 0.3727 (Fig. 7B and C).
The trauma group, which showed almost no residual hearing on
day 28 (hearing threshold: 93.7562.24 dB SPL) and thus the most
severe hearing loss (44.8664.52 dB), was marked by the most
Figure 5. Distribution of fibrosis regarding subjective ranking for all inner ear turns and all experimental groups. In all groups the
highest extend of connective tissue growth was detected in the basal turns. Fibroblast growth in more apical turns was only detected in the trauma
group and did not take place in reservoir groups at all. Significant differences between the groups were detected (plotted above the SEM bars: * = p,
0.05, *** = p,0.001; reference of the significance is marked by the thick bar) and were most prominent in the lower basal turns (p,0.001). Even
though there seems to be a tendency of increased tissue formation in the PBS group compared to the DEX group there is no statistical relevance
detectable using One-way ANOVA in combination with the Tukey post-test to compare the means between groups.
doi:10.1371/journal.pone.0104564.g005
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intense new tissue formation especially in the lower basal turn of
the cochlea (ranking score for whole cochlea: 0.8360.12;
measurement: 26.78610.21%). Animals provided with the reser-
voir plus PBS showed less tissue growth (ranking: 0.4760.08;
measurement: 4.7462.49%) and reduced hearing loss
(21.8166.18 dB) and cochleae that were treated with the DEX
reservoir developed minimal fibrotic outgrowth (ranking score:
0.2560.05; measurement: 2.1461.38%) associated with a mini-
mal loss of hearing ability 28 days after implantation (16.1564
dB).
3.5.7. Angiogenesis and osteogenesis. Additionally to
fibrotic tissue growth, an organisation of the tissue in terms of
angiogenesis was detected in 5 cochleae of the trauma group and
one ear of the reservoir + PBS group. Furthermore, in two
cochleae of the trauma group initial signs of osteogenesis were
visible (see Fig. S1D).
Discussion
The aim of this study was the evaluation of a novel hydrogel
reservoir for inner ear drug delivery in vitro and in vivo. The
hydrogel precursor NCO-sP(EO-stat-PO) possesses highly reactive
Figure 7. Correlation of hearing loss measured on day 28 and tissue reaction determined by ranking. Graph A illustrates that with the
amount of tissue reaction evaluated over the whole cochlea length the loss of residual hearing in all frequencies increases (p,0.001; r = 0.6338). This
effect is detectable in lower and higher frequency regions of the cochleae as well. In figure 7B the detected tissue reaction and hearing loss at the
upper basal turn and at 32 kHz are plotted as an example for the correlation in higher frequency areas (p,0.05; r = 0.3742). Fig. C is an example for
correlation of tissue reaction and hearing loss in lower frequency areas of the cochlea. Here we correlated hearing loss at 1 kHz and tissue growth in
the 3rd middle turn (p,0.05; r = 0.3727).
doi:10.1371/journal.pone.0104564.g007
Figure 6. In this graph the mean and SEM percentage of measurement of connective tissue growth in the scala tympani of all
experimental groups for each cochlear turn from basal to apical are plotted. The comparison of tissue growth between the groups is
illustrated by horizontal lines. Reference of the significance is marked by the thick bar. Highly significant differences were observed between tissue
growth in the trauma group and groups receiving PBS or DEX by reservoir. No differences were measured between PBS or DEX treated groups even
though a slightly increased connective tissue growth seems to be apparent in the PBS group compared to DEX treated animals. In cochleae
implanted with a PBS releasing reservoir tissue growth could be measured from basal up to the 2nd middle turn whereas in the reservoir and DEX
treated cochleae connective tissue formation was only visible in the lower and upper basal region. One-way ANOVA in combination with the Tukey
post-test was used to compare means between groups: * = p,0.05; ** = p,0.01; *** = p,0.001.
doi:10.1371/journal.pone.0104564.g006
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isocyanate (NCO) groups which can potentially react with the
alcohol groups of DEX. However, the presence of the phosphate
groups and the two sodium counter ions render the molecule
extremely hydrophilic while the isocyante groups are placed at
relatively hydrophobic iosphorne-rings. Moreover, the hydroxyl
groups of the drug molecule are directly attached to the aromatic
ring. These various properties prevent permanent covalent
binding of DEX to the hydrogel network to any detectable level
[19].The free form hydrogels exhibited the fastest release kinetics
within 24 hours as the release medium could have access to all the
3D surface of the hydrogels by which the diffusion of entrapped
drug molecules in all the direction. The drug release was by
swelling controlled diffusion process. The system where the
hydrogel was completely filled inside the silicone tube, only the
open end of the silicone tube have access to the release medium to
the hydrogel. In this configuration, the wall of the silicone tube
restricted the swelling kinetics of the hydrogel. In this system, the
drug release was purely by diffusion controlled process which took
almost 900 hours to release the loaded drug completely. In the
other system where, the hydrogel without any drug in it was only
acting as the diffusion gate, the drug from the reservoir had to
diffuse through the hydrogel gate to reach the release medium; it
took almost 1200 hours to release the drug completely. In the
1200 hours, the initial 100 hours was the lag time during which
the drug had to diffuse through the gel gate. All these three
configurations explain how the release of the drug can be
controlled precisely by checking the access of the release medium
to the hydrogels. Finally, examination of the hydrogel as a drug
delivery matrix in a medical device used for inner ear treatment in
vivo was carried out.
DEX was chosen for this drug delivery study as model drug
because of its well-known anti-inflammatory and hair cell
protective effects [6,7,20–22]. DEX suppresses apoptotic activities
in response to TNF-a. Studies performed by Messmer and
colleagues demonstrate that this effect can be achieved even up to
12 hours after TNF-a application. DEX retards the down-
regulation of inhibitors of apoptosis proteins [23], blocks
transcription of pro-inflammatory molecules and increases tran-
scription of anti-inflammatory factors and reduces leukocyte
migration through decreasing the adherence of these cells to the
vascular endothelium [24]. Synthetic glucocorticoids are also able
to decrease vascular permeability and vasodilatation, prominent
features of the inflammatory reaction and necessary for the
emigration of immune cells. Consequently, glucocorticoids reduce
oedema and fibrin formation, inhibit capillary and fibroblast
proliferation and enhance collagen breakdown [24].
These effects play an essential role in the neutralisation of
foreign bodies or bacteria raising the consideration regarding the
use of DEX in cases where infection may be likely or is actually
present. Conversely, all of these properties are necessary in the
suppression of inflammation concerning cochlear implantation.
Hence, although a precautious use of DEX is essential, it is a
noteworthy ally for offering protection of hearing ability following
cochlear implantation [25–27].
The extent of tissue response was determined both by ranking
and direct measurement. The results from both the methods were
not equal but did tend to deliver the same information. While the
measurement of 3 slices per scale per cochlea brought the quality
of objective evaluation, the subjective ranking of tissue growth in
every single slice covered a quantitative assessment. Since the
measurement was performed on 1 mid-modiolar image and the
one directly before and one directly after the modiolus, the
measured area was identical in all cochleae. This leads to a high
comparability between the cochleae but also implies that alteration
could only be detected in this specific region. Although the ranking
underlay a subjective assessment, it was exclusively performed by
one person who obliterates variation due to diverging assessment
criteria of various individuals. In addition, scoring between 0 and 3
only allowed for an unrefined classification although as a positive
factor, it involves the whole cochlea. As such, it is considered that
the subjective ranking of all slices leads to a more comprehensive
and accurate estimate of the level of tissue reaction.
Probably all distinctions between ranking results and measure-
ment results concerning p-values are based on the alteration of
modiolus-near or modiolus-distant evaluation and the fact that
three images per scale used for objective measurement may not
give a synopsis on the status of the whole cochlea. Nevertheless,
ranking and measurement methods led to similar results in most
cases, indicating that measurement can be used to support the
coarser ranking score with more detailed values.
The reservoirs remained inside the Scala tympani and interacted
with the inner ear in terms of foreign bodies over a time period of
four weeks. Nevertheless, AABR results and the distribution of
tissue growth along the cochlea length have shown that producing
a trauma as performed on animals in the trauma group, has a
more devastating influence on the structures of the inner ear. An
initial hearing loss after surgery was observed on day 3 which
remained stable over time. We consider that this initial hearing
loss is brought about by the implantation procedure as well as the
physical presence of the implant itself in the Scala tympani which
may modify the fluid and basilar membrane movement and
induce inflammatory reactions. An additional reason may be due
to mechanical damage of hair cells although this would occur only
in the basal region of the cochlea where the implant is located and
would consequently affect only the higher frequency regions. Due
to the fact that no differences in hearing loss between lower and
higher frequencies were observed, this seems unlikely.
In contrast to Braun and colleagues who reported DEX-
dependent hearing preservation without tissue reduction [28], we
observed a correlation of hearing ability and fibrosis which has
recently been reported by O’Leary [29]. These parameters depend
on the same factor, inflammation, which lends to the concept that
the tissue growth modifies the influence of the travelling wave
towards the basilar membrane which in turn reduces exhibition of
hair cells. Reduction of the nutrition requirement of sensory cells
in this area may also occur as a consequence. Additionally, tissue
proliferation inside the Scala tympani may disturb the travelling
wave on its way towards the apical turns and consequently
prohibit the stimulation of more apical sensory cells. As a result of
this, hearing of higher frequencies is reduced as well as the
sensation of low frequencies albeit the inflammation bring
localised mostly in the basal turns.
All animals of the trauma group suffered from significantly
increased hearing loss and tissue reaction compared to the other
experimental groups. We believe that the double movement of the
reservoir inside the cochlea of trauma group specimens, insertion
as the first manipulation and explantation as the second, is a valid
reason for this finding. In contrast, cochleae of the other groups
had to sustain only one traumatic manipulation.
These results indicate that common application aids that have
to be removed after usage may lead to traumatic changes of the
inner ear. Consequently we suggest that an application aid, at least
if its properties are comparable to the hydrogel reservoirs tested in
this study, should be bound to the CI and remain inside the
cochlea. Further studies concerning this topic would be necessary
to evaluate if the findings from this study are generally
representative for removable drug delivery systems. In addition
to the different mechanical stimuli, it is important to consider
Hydrogel Reservoir for Inner Ear Treatment
PLOS ONE | www.plosone.org 10 August 2014 | Volume 9 | Issue 8 | e104564
whether more immunologically active cells arrived from the blood
into the Scala tympani after the necessary rupture of the Stria
vascularis during cochleostomy in cochleae of the trauma group.
Although the opening of the cochleostomy was filled with
carboxylate cement, it was not blocked with a close-fitting implant
like the silicone reservoir and as a result the blood vessels inside the
Stria may not have been compressed. Additional irritation by the
cement may be assumed with respect to reports concerning pulpa
irritation in dental medicine [30,31] and to a newly published
study stating that dental cement, applied on guinea pig inner ears,
leads to a strong new bone formation [32], even though this
method is a widely used [33,34] and other reports have also
assessed carboxylate cement to be non-irritating [35,36].
Luttikhuizen and colleagues stated in 2006 that inflammatory
processes are related to components of the blood stream; not only
immune cells like macrophages but, for example, proteins like
fibrinogen, the complement system, antibodies and various
inflammatory factors [37]. They are attracted by chemotactic
factors that are secreted from injured tissue or by cells stressed by
the presence of foreign bodies [4,38]. Although materials of
current implants are biologically inert, they still trigger inflamma-
tory responses of the surrounding tissue. This is based upon
endogenous proteins that attach to the surface of the implant and
attract components of the nonspecific immune system. In the later
stages of the inflammatory process, following earlier leucocytic
invasion, fibroblasts migrate towards the implant and build a tissue
coating around the foreign material in order to protect the healthy
tissue. This step is clearly seen in many specimens with implanted
reservoirs (see Section 3.2.2).
Angiogenesis, another cardinal sign of inflammation, is seen in
cochleae of the trauma and reservoir + PBS group. In cochleae of
the trauma group angiogenesis had already progressed into a stage
of osteogenesis. Subsequent to fibrotic tissue growth, angiogenesis
follows as a consequence of the coagulation cascade and hypoxia
and is incited by locally released histamine and fibrin fragment E
[37]. Since most of these cells and substances are bound to the
blood stream, the correlation between the effluence of blood into
the cochlea and higher levels of inflammation must be considered.
Furthermore, the diameter and related rigidity as well as the
material composition of the inserted piece of the reservoir, played
an accessory role for the severity of the inflammatory reaction.
Previous reports by Jolly and colleagues [26] demonstrated that
electrode trauma depends on the size and flexibility of the array
and that reduction of trauma can be achieved by flexible implants
that easily adapt to the angulations of the cochlear turns. This
information can be transferred to the implantation of silicone
reservoirs that appear to be flexible which according to Jolly [26]
should provoke less irritation in the tissue of the cochlea. This
depends strongly on the composition of the material. The process
of implantation and fixation of the reservoirs explains similarities
between the impact administrated by reservoirs with either PBS or
DEX. Nevertheless, significant higher fibrosis in PBS treated ears
discovered over the whole length of the cochleae and the distinct
angiogenesis in these cochleae prove the influence of DEX applied
via the reservoir.
Conclusions
In this study, the technical feasibility of incorporating hydrogels
prepared from NCO-sP(EO-stat-PO) pre-polymers within the
silicone tube for sustained release of DEX for several weeks
through diffusion process into the inner ear was demonstrated
which encouraged the in vivo studies.
Animal experiments using normal hearing Dunkin Hartley
guinea pigs followed by treatment and regular measurement of
hearing loss showed significantly lower fibrosis in case of DEX
loaded hydrogel reservoir as compared to a PBS releasing control-
reservoir and pure trauma. Most importantly, the hearing loss was
significantly lower in case of the DEX loaded hydrogel reservoirs
as compared to the other groups. In contrast, considerable
functional and morphological changes were detected in the trauma
group. We hypothesize that the insertion and immediate
explantation of a delivery device is even more destructive to the
inner ear than the impact of a foreign body in terms of a reservoir.
Our results strongly suggest that the NCO-sP(EO-stat-PO)
hydrogel reservoir is a promising drug delivery device to apply
water-soluble drugs in therapeutically relevant doses into the inner
ear for a sustained treatment period. We conclude that the
hydrogel used in combination with a rechargeable design of
reservoir is a promising alternative of drug delivery device. This
method might be optimized by adapting the reservoir to the
cochlear implant in order to combine its insertion with the
inevitable implantation of the CI, and thus avoiding additional
trauma. This would allow surgeons to decide on the execution of
drug application during surgery.
Supporting Information
Figure S1 Representative images of tissue response
scores A) representatively depicts the score 0 mainly
detected in animals of the reservoir + DEX group. Images
B) and C) illustrate score 1 and 2 representative for the reservoir +
PBS or trauma groups. Score 3 is shown in D) which is taken from
an animal of the trauma group. In this figure the reorganization of
fibrotic tissue response (black arrow) in terms of ossification (white
arrow) is clearly seen. Asterixes: hydrogel; black arrow head:
silicone reservoir, missing in image D), taken from the trauma
group, where the tubing was implanted and subsequently
explanted.
(TIF)
Figure S2 Relevant chemical structure (A) Hydrogel
precursor and the chemical reaction of isocyanates with
H2O, (B) shows the swelling kinetics of the hydrogel
from its dry state to its fully swollen state, (C)
microporous structure of the swollen hydrogel.
(TIF)
Figure S3 Structure of dexamethasone 21-phosphate
disodium salt (DEX) and its complete release profile
from the free form hydrogel.
(TIF)
Figure S4 Experimental procedure for sample prepa-
ration of the release studies from the silicone tubes with
hydrogel gates.
(TIF)
Figure S5 Control experiment using a dye-solution
showing that the pin-hole created in the silicone tube
during loading of the DEX solution does not result in
uncontrolled release.
(TIF)
Figure S6 Picture of hydrogel-gates with three different
lengths in silicone tubes (top left), calculation of the
amount of DEX in each of the tubes (top right) and result
of the release studies (bottom).
(TIF)
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Figure S7 Frequency specific hearing loss. The mean and
SD of hearing loss of all experimental groups after 28 days of
implantation is plotted for each frequency tested. In all groups the
hearing loss seems to be less affected in the lower frequencies but
statistical evaluation did not show any significant differences
between the frequency specific hearing loss in any of the
experimental groups.
(TIF)
Figure S8 Tissue growth evaluated by ranking. The mean
6 SEM results of subjective ranking of tissue formation in the
cochlea turns of each experimental group are plotted. In all groups
the tissue reaction is significantly increased in the basal regions
compared to the middle and apical regions. Fibrotic tissue
response in more apical turns was only detected in the trauma
group (A) and did not take place in reservoir groups treated with
PBS (B) or DEX (C). One-way ANOVA in combination with the
Tukey post-test was used to compare the tissue growth within the
different cochlea turns of each experimental group: ** = p,0.01;
*** = p,0.001. Reference of the significance is marked by the
thick bar.
(TIF)
Figure S9 Tissue growth evaluated by measurement.
The mean 6 SEM percentage of scala tympani area of each
cochlea turn covered with tissue is plotted for each experimental
group. In all groups the tissue reaction is significantly increased in
the basal regions compared to the middle and apical regions.
Fibroblast growth in more apical turns was only detected in the
trauma group (A) and did not take place in reservoir groups
treated with PBS (B) or DEX (C). One-way ANOVA in
combination with the Tukey post-test was used to compare the
fibrous tissue growth within the different cochlea turns of each
experimental group: ** = p,0.01; *** = p,0.001. Reference of
the significance is marked by the thick bar.
(TIF)
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